Dr John Solomon | Head of Pharmacovigilance
Sanofi-Aventis UK

Dr John Solomon, Head of Pharmacovigilance, Sanofi-Aventis UK


John Solomon is the Head of Pharmacovigilance for UK & Ireland responsible for leading the post authorisation drug surveillance activities for the broad Sanofi portfolio including Innovative, Generics, Biologics and Vaccines products.
Prior to joining Sanofi in 2005, John was the Head of Drug Safety Europe at MDS Pharma Services.
Qualified in medicine, John has worked for over 16 years in the industry spending most of these
years in clinical drug safety and post marketing drug surveillance activities.
 
Other industry related experience includes pharmaceutical marketing and global
clinical research programmes from within the Pharmaceutical industry and Clinical Research Organisation sector respectively.
 
John is currently a pharmacovigilance representative on UK Pharmaceutical and Self-care industry trade associations.
John is especially committed to transparency around patient centric pharmacovigilance and the
commercial value of effective Pharmacovigilance.

Appearances:



World Drug Safety Europe Day Two (Wednesday 13 September ) @ 12:05

ROUNDTABLES

Master Drug Safety EU
Dr Uwe Gudat, Head of Safety, Biosimilars, Merck
Hadir Rostom, Head of the Egyptian Pharmaceutical Vigilance Center, Egyptian Pharmaceutical Vigilance Center
Pieter Stolk, Programme Manager, Lygature
Silvia Stoetter, Global PV Manager, Allergy Therapeutics
Jayne Lawrence, Chief Scientist, Royal Pharmaceutical Society of GB
sunayana shah, Head of Regulatory and Safety Policy, Association of the British Pharmaceutical Industry
Andrea Maulwurf, Head of Pharmacovigilance, EU-QPPV, Allergy Therapeutics
Michael Von Forstner, Co-chair, Pharmacovigilance Working Group, Medicines for Europe
Monika Manske, Associate Director of Global Pharmacovigilance Governance and Head of Pharmacovigilance Quality System, Mylan Pharmaceuticals Ltd

back to speakers